uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020)

uniQure (QURE) posted Non-Current Deffered Revenue of $22.4 million for Q3 2020, down 2.76% on a QoQ basis from $23.0 million in Q2 2020, and down 6.15% year-over-year from $23.9 million in Q4 2019.

Analysis

uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020) Analysis & Trends

uniQure has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $22.4 million in Q3 2020.

  • On a quarterly basis, Non-Current Deffered Revenue fell 6.15% year-over-year to $22.4 million in Q3 2020; TTM through Sep 2020 was $22.4 million, a 6.15% decrease from a year earlier, with the FY2019 full-year figure at $23.1 million, down 19.83% from the prior year.
  • Non-Current Deffered Revenue was $22.4 million for Q3 2020 at uniQure, down from $23.0 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $78.7 million in Q2 2017, with the low at $22.4 million in Q3 2020.
  • Average Non-Current Deffered Revenue over 5 years is $41.4 million, with a median of $29.4 million recorded in 2018.
  • The sharpest annual moves came in 2018 and 2020: Non-Current Deffered Revenue tumbled 58.27% in 2018, then declined 6.15% in 2020.
  • Over 5 years, Non-Current Deffered Revenue stood at $75.6 million in 2016, then declined by 10.85% to $67.4 million in 2017, then tumbled by 57.18% to $28.9 million in 2018, then dropped by 19.83% to $23.1 million in 2019, then dropped by 3.13% to $22.4 million in 2020.
  • The last three Non-Current Deffered Revenue figures came in at $22.4 million (Q3 2020), $23.0 million (Q2 2020), and $23.7 million (Q1 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 22.41 Mn
Jun 30, 2020 23.05 Mn
Mar 31, 2020 23.71 Mn
Dec 31, 2019 23.14 Mn
Sep 30, 2019 23.88 Mn
Jun 30, 2019 26.35 Mn
Mar 31, 2019 27.47 Mn
Dec 31, 2018 28.86 Mn
Sep 30, 2018 29.85 Mn
Jun 30, 2018 32.85 Mn
Mar 31, 2018 36.15 Mn
Dec 31, 2017 67.41 Mn
Sep 30, 2017 67.86 Mn
Jun 30, 2017 78.73 Mn
Mar 31, 2017 75.40 Mn
Dec 31, 2016 75.61 Mn
Dec 31, 2015 83.45 Mn
API Access

uniQure Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=QURE&period=max&api_key=YOUR_API_KEY